Exothera
Arnaud LACOMBE is currently the Head of Project Management at EXOTHERA, a contract development and manufacturing organization specializing in cell and gene therapy. Prior to this role, Arnaud worked as a Senior Project Manager at Univercells, Novasep Belgium, MaSTherCell, NVH Medicinal, and Promogène, where he was involved in various project management and development positions within the biotechnology and pharmaceutical industries. Arnaud also has experience as a Postdoctoral Fellow at INSERM U526 in France and the Montreal Jewish General Hospital, where he conducted research projects related to cancer treatments and DNA repair. Arnaud holds a Doctorat in Molecular and Cellular Biology from UCLA and a Master's degree in Cellular Engineering from Université de Poitiers.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660